The 2025 Newborn Screening and Genomics Roundtable

Newborn genetic testing is gaining attention in medical communities worldwide. As we explore how genomic sequencing can complement traditional newborn screening programs, significant questions about implementation, ethics, and clinical utility have surfaced.

In response to these uncertainties, we're pleased to present the Newborn Screening and Genomics Roundtable, offering expert perspectives on the road ahead. This compelling discussion builds on Revvity's 2024 World View roundtable, reconvening the same distinguished experts to address brand new questions.

Panelists:

• David Bick | Clinical Advisor for the Newborn Genomes Programme, Genomics England Limited
• Holly Peay | Senior Research Scientist, Independent Researcher
• Asbjørg Stray-Pedersen | Researcher and Senior Consultant, Norwegian National Unit for Newborn Screening
• Amy Gaviglio | Founder and CEO, Genetic Counselor, Connetics Consulting, LLC

Moderator:

• Madhuri Hegde | Senior Vice President and Chief Scientific Officer, Revvity

Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.